Lis Leiderman Chair of the Audit CommitteeMember of the Compensation Committee Lis Leiderman Director Financial Expert
bluebird bio Sets Record Date and Distribution Date for Planned Business Separation Read more about bluebird bio Sets Record Date and Distribution Date for Planned Business Separation
bluebird bio Provides Update on Upcoming Planned Business Separation Read more about bluebird bio Provides Update on Upcoming Planned Business Separation
bluebird bio Submits Biologics License Application (BLA) to FDA for betibeglogene autotemcel (beti-cel) Gene Therapy for Patients With β-thalassemia Who Require Regular Red Blood Cell Transfusions Read more about bluebird bio Submits Biologics License Application (BLA) to FDA for betibeglogene autotemcel (beti-cel) Gene Therapy for Patients With β-thalassemia Who Require Regular Red Blood Cell Transfusions
2seventy bio Announces Upcoming Investor Events Read more about 2seventy bio Announces Upcoming Investor Events
bluebird bio Secures $75 Million in Private Placement Equity Financing Read more about bluebird bio Secures $75 Million in Private Placement Equity Financing
bluebird bio at Morgan Stanley 19th Annual Healthcare Conference Read more about bluebird bio at Morgan Stanley 19th Annual Healthcare Conference
bluebird bio Announces Key Management and Board Appointments and Upcoming Investor Events Read more about bluebird bio Announces Key Management and Board Appointments and Upcoming Investor Events
bluebird bio Reports Second Quarter Financial Results and Provides Operational Update Read more about bluebird bio Reports Second Quarter Financial Results and Provides Operational Update